Scarica l'app Stockscreener
521.11
0.19%
0.99
Dopo l'orario di chiusura:
521.11
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TMO Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$520.12
Aprire:
$515.73
Volume 24 ore:
2.03M
Relative Volume:
0.95
Capitalizzazione di mercato:
$195.79B
Reddito:
$44.56B
Utile/perdita netta:
$6.73B
Rapporto P/E:
29.38
EPS:
17.7391
Flusso di cassa netto:
$6.29B
1 W Prestazione:
+1.99%
1M Prestazione:
-16.48%
6M Prestazione:
+6.76%
1 anno Prestazione:
-0.41%
Intervallo 1D:
$509.48
$521.28
Intervallo di 1 settimana:
$505.80
$521.63
Portata 52W:
$385.46
$643.99
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Nome
Thermo Fisher Scientific Inc
Settore
Industria
Telefono
(781) 622-1000
Indirizzo
168 THIRD AVENUE, WALTHAM, MA
Compare TMO vs DHR, IDXX, A, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
521.11 | 195.41B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
210.64 | 148.05B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
656.73 | 52.76B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
121.38 | 34.22B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
319.38 | 31.67B | 3.17B | 642.63M | 516.49M | 10.77 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-11 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-12-09 | Iniziato | Goldman | Buy |
| 2025-12-08 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-12-02 | Ripresa | Morgan Stanley | Overweight |
| 2025-12-01 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2025-09-11 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-08-19 | Iniziato | William Blair | Outperform |
| 2025-07-24 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-07-11 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | Downgrade | UBS | Buy → Neutral |
| 2025-01-10 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Iniziato | Scotiabank | Sector Perform |
| 2024-10-14 | Iniziato | Redburn Atlantic | Buy |
| 2024-10-01 | Iniziato | Stephens | Overweight |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-03-18 | Ripresa | Citigroup | Neutral |
| 2024-01-24 | Downgrade | Barclays | Overweight → Equal Weight |
| 2024-01-08 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | Iniziato | HSBC Securities | Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-10-26 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | Iniziato | Bernstein | Outperform |
| 2023-09-06 | Ripresa | Citigroup | Buy |
| 2023-07-19 | Iniziato | Raymond James | Outperform |
| 2023-07-19 | Reiterato | Robert W. Baird | Outperform |
| 2023-07-13 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | Reiterato | Barclays | Overweight |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-10-27 | Downgrade | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-04-25 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | Ripresa | Barclays | Overweight |
| 2021-10-20 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-16 | Iniziato | The Benchmark Company | Buy |
| 2021-03-18 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2021-01-08 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | Downgrade | Citigroup | Buy → Neutral |
| 2020-12-02 | Iniziato | Goldman | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-14 | Iniziato | Morgan Stanley | Overweight |
| 2020-08-20 | Ripresa | JP Morgan | Overweight |
| 2020-07-15 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2020-07-07 | Reiterato | Needham | Buy |
| 2020-04-23 | Reiterato | Needham | Buy |
| 2020-01-31 | Reiterato | Needham | Buy |
| 2020-01-22 | Iniziato | Credit Suisse | Neutral |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-07-25 | Reiterato | Needham | Buy |
| 2019-07-16 | Downgrade | Needham | Strong Buy → Buy |
| 2019-05-30 | Iniziato | Wolfe Research | Outperform |
| 2019-05-23 | Reiterato | Needham | Strong Buy |
| 2019-04-22 | Reiterato | Needham | Strong Buy |
| 2019-04-16 | Reiterato | BofA/Merrill | Buy |
Mostra tutto
Thermo Fisher Scientific Inc Borsa (TMO) Ultime notizie
Harvest Portfolios Group Inc. Sells 4,403 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc. $TMO Stock Holdings Decreased by Huntington National Bank - MarketBeat
Intech Investment Management LLC Sells 5,099 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
How Does Thermo Fisher Scientific Stock Stack Up Against Its Peers? - Trefis
Artisan Partners Limited Partnership Grows Stake in Thermo Fisher Scientific Inc. $TMO - MarketBeat
The immortal life of Henrietta Lacks lawsuits gets a bit shorter with Novartis settlement - Fortune
Thermo Fisher extends two leases in Middleton - The Daily Reporter
The "Flight to Quality": Thermo Fisher’s Q4 Beat and Dividend Hike Cement Defensive Leadership for 2026 - The Chronicle-Journal
TIAA Trust National Association Buys 7,064 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Xponance Inc. Sells 3,464 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Handelsbanken Fonder AB Boosts Stake in Thermo Fisher Scientific Inc. $TMO - MarketBeat
PCR Technologies Market Is Going to Boom Rapidly | Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd. - openPR.com
Erste Asset Management GmbH Trims Stock Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Stock To $390? - Trefis
Decoding Thermo Fisher Scientific Inc (TMO): A Strategic SWOT In - GuruFocus
Here's What Analysts Think About Thermo Fisher Scientific (TMO) Post Earnings - Finviz
Here’s What Analysts Think About Thermo Fisher Scientific (TMO) Post Earnings - Yahoo Finance
Thermo Fisher Scientific Finalizes $3.8 Billion Senior Notes Offering - Global Legal Chronicle
Did Thermo Fisher’s (TMO) 10% Dividend Hike After Earnings Beat Just Reframe Its Capital Return Story? - simplywall.st
Thermo Fisher Scientific Inc. (NYSE:TMO) Announces Quarterly Dividend of $0.47 - MarketBeat
Westpac Banking Corp Increases Stock Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Introduces New Laboratory Developed Test to Help Transplant Patients Receive the Right Dose of Critical Anti-Rejection Medication Sooner - Business Wire
Precision Medicine Market 2026–2031 Growth: 13%+ CAGR as AI Integration and Biomarker Advancements Drive Adoption, Reports Mordor Intelligence - GlobeNewswire Inc.
Thermo Fisher Scientific (TMO) Boosts Dividend by 10% - GuruFocus
Thermo Fisher Announces 10% Increase in Quarterly Dividend - Intellectia AI
Why Analysts Are Closely Watching Thermo Fisher Scientific Inc. (TMO) - Finviz
Thermo Fisher Scientific Increases Quarterly Dividend - PharmiWeb.com
Thermo Fisher Scientific (TMO) Announces Future Dividend Payment - GuruFocus
Thermo Fisher raises quarterly dividend 10% to $0.47 per share - Investing.com
Thermo Fisher raises quarterly dividend 10% to $0.47 per share By Investing.com - Investing.com South Africa
How Is Thermo Fisher Scientific’s Stock Performance Compared to Other Medical Devices Stocks? - Barchart.com
Thermo Fisher Datavant Deal Deepens Real World Data Role In Trials - Yahoo Finance UK
Scientific Data Management System Market Is Going to Boom - openPR.com
Thermo Fisher Scientific Inc. $TMO Shares Acquired by Magellan Asset Management Ltd - MarketBeat
Digital Cytology Market Is Going to Boom | Roche • Thermo Fisher Scientific • PerkinElmer - openPR.com
Parasitology Market Is Going to Boom | Thermo Fisher Scientific • Merck KGaA • Abbott Laboratories - openPR.com
Thermo Fisher Scientific to Present at Raymond James Annual Institutional Investors Conference - BioSpace
Assessing Thermo Fisher Scientific (TMO) Valuation After Recent Share Price Pullback - simplywall.st
FDA Approved Thermo Fisher Scientific’s (TMO) Oncomine Dx Express Test - MSN
Thermo Fisher Scientific Inc. (TMO) Carries a Mid-Single Digit Organic Growth Forecast - Finviz
Thermo Fisher’s Datavant Data Tie-Up Could Be A Game Changer For Thermo Fisher Scientific (TMO) - Yahoo Finance
How Is The Market Feeling About Thermo Fisher Scientific Inc? - Benzinga
Thermo Fisher CEO to speak at Raymond James investor event - Stock Titan
Innovating Texture and Culture in Plant-Based Foods - News-Medical
Next Generation Sequencing Market Competitive Landscape - GlobeNewswire
Next Generation Sequencing Market Competitive Landscape Report 2025 Featuring Top PlayersThermo Fisher Scientific, Pacific Biosciences, Illumina, Roche - Yahoo Finance
Ion Chromatography Market Is Going to Boom |• Thermo Fisher Scientific • Agilent Technologies - openPR.com
Bioprocessing Reagents Market Is Going to Boom |• Thermo Fisher Scientific • Merck KGaA - openPR.com
Thermo Fisher Scientific (TMO) Valuation Check As Datavant Data Partnership Draws Fresh Investor Interest - Yahoo Finance
Thermo Fisher boosts connected planning with Oracle Cloud EPM - Oracle
Thermo Fisher-Clario deal open for views in EU - MLex
Thermo Fisher Scientific Inc Azioni (TMO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.61%
0.60%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):